FDA DEVICE FACTS
Brain WMH
Quantib B.V.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Intended Use Brain WMH is intended for automatic labeling, visualization, and volumetric quantification of WMH from T2w FLAIR MR images. The output consists of segmentations, visualizations and volumetric measurements of WMH. It is intended to provide the trained medical professional with complementary information for the evaluation and assessment of MR brain images and to aid the trained medical professional in quantitative reporting. Intended User Population The intended users of Brain WMH are trained medical professionals. Intended Patient Population Brain WMH is intended for post-processing of brain magnetic resonance imaging (MRI) data from patients 22 years of age or older, without pathologies (e.g. tumor or stroke), and treatment induced features (e.g. from prior surgery or radiation treatment), and without contrast enhancement.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。